These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


99 related items for PubMed ID: 632589

  • 1. Natural killing in immunodeficient patients.
    Koren HS, Amos DB, Buckley RH.
    J Immunol; 1978 Mar; 120(3):796-9. PubMed ID: 632589
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. NK cell function in severe combined immunodeficiency (SCID): evidence of a common T and NK cell defect in some but not all SCID patients.
    Peter HH, Friedrich W, Dopfer R, Müller W, Kortmann C, Pichler WJ, Heinz F, Rieger CH.
    J Immunol; 1983 Nov; 131(5):2332-9. PubMed ID: 6415162
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma.
    Muralikrishna K, Varalakshmi C, Khar A.
    Cytokines Cell Mol Ther; 1997 Mar; 3(1):51-8. PubMed ID: 9287244
    [Abstract] [Full Text] [Related]

  • 7. Natural killing and antibody-dependent cellular cytotoxicity are mediated by different mechanisms and by different cells.
    Koren HS, Williams MS.
    J Immunol; 1978 Nov; 121(5):1956-60. PubMed ID: 81858
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Interleukin (IL)-15 enhances antibody-dependent cellular cytotoxicity and natural killer activity in neonatal cells.
    Nguyen QH, Roberts RL, Ank BJ, Lin SJ, Thomas EK, Stiehm ER.
    Cell Immunol; 1998 May 01; 185(2):83-92. PubMed ID: 9636686
    [Abstract] [Full Text] [Related]

  • 10. In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells.
    Burns GF, Triglia T, Werkmeister JA.
    J Immunol; 1984 Sep 01; 133(3):1656-63. PubMed ID: 6611374
    [Abstract] [Full Text] [Related]

  • 11. lenalidomide enhances natural killer cell and monocyte-mediated antibody-dependent cellular cytotoxicity of rituximab-treated CD20+ tumor cells.
    Wu L, Adams M, Carter T, Chen R, Muller G, Stirling D, Schafer P, Bartlett JB.
    Clin Cancer Res; 2008 Jul 15; 14(14):4650-7. PubMed ID: 18628480
    [Abstract] [Full Text] [Related]

  • 12. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
    Colotta F, Peri G, Villa A, Mantovani A.
    J Immunol; 1984 Feb 15; 132(2):936-44. PubMed ID: 6690624
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of natural killing with antibody dependent cell mediated cytotoxicity in patients with systemic lupus erythematosus.
    Kozlowski SH, Hirsen DJ, Jackson EJ.
    J Rheumatol; 1982 Feb 15; 9(1):59-62. PubMed ID: 7086780
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The genetic deficiency of leukocyte surface glycoprotein Mac-1, LFA-1, p150,95 in humans is associated with defective antibody-dependent cellular cytotoxicity in vitro and defective protection against herpes simplex virus infection in vivo.
    Kohl S, Loo LS, Schmalstieg FS, Anderson DC.
    J Immunol; 1986 Sep 01; 137(5):1688-94. PubMed ID: 3528287
    [Abstract] [Full Text] [Related]

  • 18. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
    Bonavida B, Lebow LT, Bradley TP.
    J Immunol; 1984 Feb 01; 132(2):594-8. PubMed ID: 6606675
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Interleukin 2-dependent natural killer (NK) cell lines from patients with primary T cell immunodeficiencies.
    Flomenberg N, Welte K, Mertelsmann R, O'Reilly R, Dupont B.
    J Immunol; 1983 Jun 01; 130(6):2635-43. PubMed ID: 6222110
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.